Neurocrine Biosciences, Inc.
NBIX
$155.80
$5.213.46%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -11.09% | 32.80% | 14.27% | 3.40% | -12.32% |
| Total Receivables | 11.84% | -5.66% | 22.21% | 15.45% | 7.70% |
| Inventory | -6.52% | -0.43% | 21.79% | -3.72% | 2.96% |
| Prepaid Expenses | 31.69% | -4.15% | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -46.03% | 69.79% | -43.50% | 1.17% | 87.58% |
| Total Current Assets | -3.43% | 16.88% | 23.41% | 6.78% | -5.03% |
|
|
|||||
| Total Current Assets | -3.43% | 16.88% | 23.41% | 6.78% | -5.03% |
| Net Property, Plant & Equipment | -1.32% | -3.71% | -3.05% | -0.88% | -0.47% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -4.03% | 2.20% | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 19.80% | -2.31% | -30.37% | 8.49% | -4.28% |
| Total Assets | 5.93% | 8.58% | 9.66% | 5.48% | -0.83% |
|
|
|||||
| Total Accounts Payable | 14.39% | -12.51% | 14.63% | -4.91% | 10.11% |
| Total Accrued Expenses | -6.94% | 7.97% | 29.29% | 5.71% | -3.38% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.32% | 9.16% | 1.18% | 11.18% | -- |
| Total Finance Division Other Current Liabilities | 131.57% | 3,279.17% | -92.45% | 15.64% | -50.98% |
| Total Other Current Liabilities | 131.57% | 3,279.17% | -92.45% | 15.64% | -50.98% |
| Total Current Liabilities | 11.88% | 16.52% | 16.79% | 4.48% | 2.99% |
|
|
|||||
| Total Current Liabilities | 11.88% | 16.52% | 16.79% | 4.48% | 2.99% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -2.19% | -3.06% | -2.44% | -1.88% | -1.67% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 18.75% | 12.26% | -6.85% | 15.69% | 9.27% |
| Total Liabilities | 8.73% | 9.21% | 5.57% | 3.78% | 2.04% |
|
|
|||||
| Common Stock & APIC | 0.90% | 3.56% | 3.82% | 2.58% | -0.89% |
| Retained Earnings | 31.70% | 52.28% | 247.93% | 1,694.34% | -118.15% |
| Treasury Stock & Other | -96.95% | -0.76% | 5.60% | 38.89% | 55.17% |
| Total Common Equity | 4.74% | 8.31% | 11.48% | 6.25% | -2.09% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 4.74% | 8.31% | 11.48% | 6.25% | -2.09% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 4.74% | 8.31% | 11.48% | 6.25% | -2.09% |
|
|
|||||